Home

Cellectis S.A. - American Depositary Shares (CLLS)

3.9800
-0.5400 (-11.95%)
NASDAQ · Last Trade: Oct 17th, 5:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Thursday's session: gap up and gap down stockschartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · October 16, 2025
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · October 16, 2025
Top 2 Health Care Stocks That May Keep You Up At Night This Monthbenzinga.com
Via Benzinga · October 16, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · October 16, 2025
Earnings Scheduled For August 4, 2025benzinga.com
Via Benzinga · August 4, 2025
Earnings Scheduled For May 12, 2025benzinga.com
Via Benzinga · May 12, 2025
Wondering what's happening in today's pre-market session?chartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 29, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via Benzinga · September 29, 2025
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1 results.
Via Benzinga · September 29, 2025
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.
Via Benzinga · September 29, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 19, 2025
Top 5 Biotech Stocks With Strong Momentumbenzinga.com
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via Benzinga · August 28, 2025
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 29, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · July 25, 2025
What's going on in today's sessionchartmill.com
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via Chartmill · July 25, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · July 14, 2025
Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.
Via MarketBeat · April 22, 2025
The market is filled with gapping stocks in Friday's session.chartmill.com
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · April 11, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · March 14, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 14, 2025
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 14, 2025
Earnings Scheduled For March 13, 2025benzinga.com
Via Benzinga · March 13, 2025
CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q2 2024investorplace.com
CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024
CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q1 2024investorplace.com
CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 28, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 7, 2024